4.6 Article

Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist

Journal

JOURNAL OF VIROLOGY
Volume 87, Issue 22, Pages 12489-12495

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01845-13

Keywords

-

Categories

Funding

  1. European Union [223498]
  2. ANTIGONE [278976]
  3. German Research Foundation (DFG) [DR 772/3-1, MU3564/1-1]
  4. German Ministry of Education and Research (BMBF SARS II) [01KI1005A]
  5. DFG [BA3544/1-1, SFB 704]
  6. [01KI0705]
  7. [We 2616/7-1]

Ask authors/readers for more resources

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe acute respiratory infection with as yet unclear epidemiology. We previously showed that MERS-CoV counteracts parts of the innate immune response in human bronchiolar cells. Here we analyzed accessory proteins 3, 4a, 4b, and 5 for their abilities to inhibit the type I interferon response. Accessory protein 4a was found to block interferon induction at the level of melanoma differentiation-associated protein 5 (MDA5) activation presumably by direct interaction with double-stranded RNA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available